Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T De Somer

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Acta Gastro-Enterologica Belgica|July 14, 2022
The impact of rifaximin on the hospital burden and infections in patients with hepatic encephalopathy: a retrospective observational studyJ De Graeve, E Vanderstraeten, T Delvaeye, et al.
Acta Gastro-Enterologica Belgica|July 4, 2021
An atypical cause of right lower abdominal pain: amoebiasis, a family clusterT De Somer, D Baert, M Deceuninck, et al.
Acta Gastro-Enterologica Belgica|December 25, 2022
Evaluation of the safety and effectiveness after switch from adalimumab originator to biosimilar SB5 in patients with inflammatory bowel disease in a real-life settingN Deprez, T De Somer, D Baert, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Acta Gastro-Enterologica Belgica|July 14, 2022
The impact of rifaximin on the hospital burden and infections in patients with hepatic encephalopathy: a retrospective observational studyJ De Graeve, E Vanderstraeten, T Delvaeye, et al.
Acta Gastro-Enterologica Belgica|July 4, 2021
An atypical cause of right lower abdominal pain: amoebiasis, a family clusterT De Somer, D Baert, M Deceuninck, et al.
Acta Gastro-Enterologica Belgica|December 25, 2022
Evaluation of the safety and effectiveness after switch from adalimumab originator to biosimilar SB5 in patients with inflammatory bowel disease in a real-life settingN Deprez, T De Somer, D Baert, et al.
Pageof 1